We found that the MALAT1 expression level was gradually increased in ESCC patients in line with WHO stage (P=0.0395, P=0.0331, Figure 1B, Table 2) and revealed that MALAT1 was predominantly up-regulated in late-stage tumor tissues. This evidence concerns the gene MALAT1 and neoplasm.